Analysis & Findings

Analysis Focus

This page looks at women aged 25 to 60 who have a Cancer diagnosis, came in through the Emergency department, and left with Inconclusive test results. It is a concerning pattern — these are active cancer patients who went through an emergency visit and still walked away without a clear answer. The data explores what that looks like financially and clinically across this group.

Key Findings

Billing amounts across this group vary widely, which shows that even within a narrow patient profile the cost of care is far from consistent. The fact that every patient here had an Inconclusive result despite an Emergency admission suggests that a single visit often is not enough to get answers for cancer patients — and that likely means more follow-up visits and higher costs down the line.

Clinical & Policy Implications

These findings point to a real gap in how cancer patients are handled during emergency visits. Faster access to oncology specialists, better triage for known cancer patients, and stronger outpatient follow-up programs could all help reduce visits that end without a conclusive result. From a policy standpoint, investing in preventive care and early detection for this age group could reduce emergency dependency and bring down the unpredictable costs this data reflects.

Page Premise
Insight: This page examines female patients between the ages of 25 and 60 who were admitted through the Emergency pathway with a Cancer diagnosis and received Inconclusive test results. Cancer patients presenting through emergency care with unresolved test outcomes may be experiencing delayed diagnoses or inadequate screening, leading to higher billing costs and uncertainty in treatment. Both queries below use the same filters.
Gender: Female Age: 25–60 Admission: Emergency Condition: Cancer Test Results: Inconclusive
Statistical Summary
Total Patients
15
Average Age
39.7
Total Billing
$241,496
Avg Bill / Patient
$16,100
Detailed Patient Records
Showing 15 records — All patients: Female, ages 25–60, admitted via Emergency, condition: Cancer, test result: Inconclusive. Sorted by billing amount, highest first.
# Name Age Blood Type Medication Doctor Hospital Insurance Provider Date Admitted Billing Amount
1 crYstAl simPSon 37 A+ Paracetamol Sara Simmons and Valencia Flores, Byrd Blue Cross 2023-11-16 $35,722.02
2 sHarOn CHapmAn 38 A- Aspirin Bradley Bryant Miller PLC Cigna 2020-08-02 $31,446.97
3 mARK sERRaNo 29 B- Lipitor Kyle Hancock and Chandler, Conner Miller Blue Cross 2022-07-24 $26,873.01
4 herbErT jiMEneZ 41 AB- Lipitor Jenna Thomas Thomas and Nguyen, King Aetna 2024-01-03 $26,036.67
5 TarA LI 37 O+ Aspirin Kurt Flowers Pratt Inc Aetna 2023-01-18 $25,816.42
6 conNie GomEz 33 B- Lipitor Elizabeth Fields Inc Santos Blue Cross 2019-06-18 $22,317.68
7 JONathan clarKE 55 O+ Ibuprofen Molly Rios French Ltd UnitedHealthcare 2023-04-17 $13,964.15
8 DERek LAwSoN 25 B+ Paracetamol Ashley Warner Lewis, Gibbs and Powell Aetna 2019-07-08 $12,950.76
9 kEvIN jEFFeRsON 45 B+ Aspirin Jason Miller Griffin and Lyons Rivers, Cigna 2020-03-14 $12,356.56
10 JASmine sHort 40 O- Lipitor Amy Johnson Bailey-Hunt Medicare 2021-02-23 $8,867.75
11 robeRT GArciA 55 B- Ibuprofen Erik Santos Inc Wyatt Blue Cross 2022-12-01 $7,949.35
12 AmBer andeRSoN 25 A+ Aspirin Joseph Chandler Heath-Brown UnitedHealthcare 2024-04-29 $6,162.35
13 cyNthIA thOmAs 44 B+ Paracetamol Aaron Turner Johnson PLC Medicare 2019-05-13 $4,794.75
14 mAria GArdNEr 35 B+ Lipitor Stephanie Herrera Jarvis-Roberts Aetna 2020-08-23 $4,415.75
15 AlaN lEe 57 AB- Penicillin Shirley Armstrong Castaneda-Powell Blue Cross 2023-05-31 $1,821.35